Applied Genetic earnings miss, Revenue beats in Q1

  • Investing.com
Applied Genetic earnings miss, Revenue beats in Q1

Investing.com - Applied Genetic reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.

Applied Genetic announced earnings per share of $-0.360 on revenue of $325.0K. Analysts polled by Investing.com anticipated EPS of $-0.334 on revenue of $0.00.

Applied Genetic shares are down 67.82% from the beginning of the year and are trading at $0.290 , down-from-52-week-high.

Applied Genetic follows other major Healthcare sector earnings this month

Applied Genetic's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.

Veeva Systems A had beat expectations on Wednesday, August 31, 2022 with second quarter EPS of $1.03 on revenue of $534.22M, compared to forecast for EPS of $1.01 on revenue of $530.71M.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles